EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The oxygenated complexes of the two catalytically active oxidation-reduction states of L-tryptophan-2,3-dioxygenase



The oxygenated complexes of the two catalytically active oxidation-reduction states of L-tryptophan-2,3-dioxygenase



Journal of Biological Chemistry 250(13): 5041-5048



The oxygenated complexes of the two catalytically active forms of pseudomonad and rat liver L-tryptophan-2,3-dioxygenase (EC 1.13.11.11) have been studied. As was previously reported (ISHIMURA, Y., NORZAKI, M., HAYAISHI, O., TAMURA, M., AND YAMAZAK-I I. (1970) J. Biol. Chem. 245, 3593-3602), we observe that the fully reduced form of pseudomonad tryptophan oxygenase during steady state catalysis exists predominantly as the L-tryptophan ferroheme-O2 enzyme complex (lambdamax = 415 nm, 540 nm, 570 nm). However, during steady state catalysis by a half-reduced form of both the pseudomonad and hepatic enzymes, the predominant species present manifest absorption spectra indicative of ternary complexes in which all the heme exists as ferriheme (Soret, 407 nm), there being no trace of a ferroheme-O2 complex. Carbon monoxide is a competitive inhibitor with respect to molecular oxygen of catalysis by either the half-reduced or fully reduced forms of pseudomonad tryptophan oxygenase. During steady state catalysis in the presence of CO, the fully reduced form of the enzyme exists as a mixture of the oxyferroheme (Soret = 415 nm) and carboxyferroheme (Soret = 421 nm) enzyme complexes. However, if the same experiment is repeated with the half-reduced form of the pseudomonad enzyme, all of the enzyme is in the ferriheme state, even though CO is inhibiting this form of the enzyme to the same degree as it does the fully reduced form. We conclude that for the half-reduced form of pseudomonad tryptophan oxygenase the substrate, O2, and the inhibitor, CO, are not binding to the heme moieties, but are bound elsewhere, presumably to the Cu(I) moieties. Examination of the kinetic mechanisms of the half-reduced and fully reduced forms of pseudomonad tryptophan oxygenase using the inhibitors carbon monoxide and 5-fluorotryptophan confirmed that the fully reduced enzyme binds L-tryptophan before O2 (FORMAN, H., AND FEIGELSON, P. (1971) Biochemistry 10, 760-763) and that for the half-reduced enzyme O2 binds first. In the presence of 5-fluorotryptophan a relatively stable oxyferroheme enzyme complex was generated with the fully reduced form of pseudomonad tryptophan oxygenase. Thus, saturation of the catalytic site alone either with the substrate, L-tryptophan, or the competitive inhibitor, 5-fluorotryptophan, enhances binding of O2 to the ferroheme moieties of the enzyme. The resistance of this complex to photolysis indicates that the bound molecular oxygen is predominantly present as superoxide, O2-minus.

(PDF 0-2 workdays service: $29.90)

Accession: 041708196

Download citation: RISBibTeXText

PMID: 1150654



Related references

The oxygenated complexes of the 2 catalytically active oxidation reduction states of tryptophan 2 3 di oxygenase ec 1.13.11.11. Journal of Biological Chemistry 250(13): 5041-5048, 1975

Oxygenated complexes of the 2 catalytically active forms of l tryptophan 2 3 di oxygenase. Federation Proceedings 33(5 PART 2): 1292, 1974

Magnetic and natural circular dichroism of L-tryptophan 2,3-dioxygenases and indoleamine 2,3-dioxygenase. II. Spectra of their ferric cyanide and ferrous carbon monoxide complexes and an oxygenated form. Journal of Biological Chemistry 258(4): 2526-2533, 1983

Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase. Biochemical Society Transactions 37(Pt 2): 408-412, 2009

Ir-Catalyzed asymmetric allylic substitutions with (phosphoramidite)Ir complexes-resting states, synthesis, and characterization of catalytically active (pi-allyl)Ir complexes. Chemistry 15(42): 11087-11090, 2009

Ir-catalysed asymmetric allylic substitutions with cyclometalated (phosphoramidite)Ir complexes--resting states, catalytically active (pi-allyl)Ir complexes and computational exploration. Chemistry 16(22): 6601-6615, 2010

Contributions of tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase to the conversion of D-tryptophan to nicotinamide analyzed by using tryptophan 2,3-dioxygenase-knockout mice. Bioscience, Biotechnology, and Biochemistry 78(5): 878-881, 2015

Monitoring in situ catalytically active states of Ru catalysts for different methanol oxidation pathways. Physical Chemistry Chemical Physics 9(27): 3648-3657, 2007

Functionalization of silicon surfaces with catalytically active Pd complexes and application to the aerobic oxidation of benzylic alcohols. Chemical Communications: 4280-4282, 2008

The oxygenated form of L-tryptophan 2,3-dioxygenase as reaction intermediate. Journal of Biological Chemistry 245(14): 3593-3602, 1970

Studies on the acid unfolded and molten globule states of catalytically active stem bromelain: a comparison with catalytically inactive form. Journal of Biochemistry 140(4): 501-508, 2006

Dinuclear nickel complexes in five states of oxidation using a redox-active ligand. Inorganic Chemistry 53(21): 11770-7, 2014

Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. Journal of Biological Chemistry 275(12): 8501-8507, 2000

Tryptophan degradation by indoleamine 2, 3-dioxygenase and tryptophan 2, 3-dioxygenase in murine concepti. Kawasaki Igakkai Shi 28(1): 1-9, 2002